Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
暂无分享,去创建一个
[1] A. Tarkowski,et al. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies , 1994, European journal of immunology.
[2] R. Hohlfeld,et al. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. , 1998, Journal of immunology.
[3] J. Mendell,et al. Inclusion body myositis , 1995, Neurology.
[4] T. Sumida,et al. Restricted junctional usage of T cell receptor V beta 2 and V beta 13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjögren's syndrome. , 1992, Arthritis and rheumatism.
[5] M. Dalakas,et al. Polymyositis inpatients infected with human T‐cell leukemia virus type I: The role of the virus in the cause of the disease , 1994, Annals of neurology.
[6] D. Carlo,et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] Andrew G. Engel,et al. αB-Crystallin immunolocalization yields new insights into inclusion body myositis , 2000, Neurology.
[8] A. Engel,et al. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls , 1995, Journal of Neuroimmunology.
[9] H. Goebel,et al. Cytokine Expression Profile in Idiopathic Inflammatory Myopathies , 1996, Journal of neuropathology and experimental neurology.
[10] M. Dalakas,et al. Molecular immunology and genetics of inflammatory muscle diseases. , 1998, Archives of neurology.
[11] M. Dalakas. Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.
[12] M. Dalakas,et al. Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis , 1998, Muscle & nerve.
[13] E. Heber-Katz,et al. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.
[14] H. Goebel,et al. Expression of cell adhesion molecules in inflammatory myopathies , 1995, Journal of Neuroimmunology.
[15] Jingwu Z. Zhang,et al. Clonal expansion of myelin basic protein‐reactive T cells in patients with multiple sclerosis: Restricted T cell receptor V gene rearrangements and CDR3 sequence , 1995, European journal of immunology.
[16] A. Begovich,et al. Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.
[17] M. Dalakas,et al. HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies , 1998, Journal of Neuroimmunology.
[18] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.
[19] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.
[20] R. Cattaneo,et al. Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis , 1991 .
[21] F. Breedveld,et al. T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. , 1993, Human immunology.
[22] L. Steinman,et al. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. , 1992, BioTechniques.
[23] P. Gregersen,et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. , 1996, Journal of immunology.
[24] M. Dalakas,et al. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. , 1999, The American journal of pathology.
[25] D. Hafler,et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. , 1994, Journal of immunology.
[26] M. Dalakas,et al. The αβ T-Cell Receptor Repertoire in Inclusion Body Myositis: Diverse Patterns of Gene Expression by Muscle-infiltrating Lymphocytes , 1994 .
[27] Marinos C. Dalakas. Immunopathogenesis of inflammatory myopathies , 1995, Annals of neurology.
[28] Christopher Lindberg,et al. Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis , 1997, Journal of Neuroimmunology.
[29] Reinhard Hohlfeld,et al. T-cell heterogeneity in muscle lesions of inclusion body myositis , 1998, Journal of Neuroimmunology.
[30] A. Oldfors,et al. Limited T‐Cell Receptor V Gene Usage in Inclusion Body Myositis , 1996, Scandinavian journal of immunology.
[31] D. Hafler,et al. TCR usage in human and experimental demyelinating disease. , 1996, Immunology today.
[32] A. Engel,et al. Expression of Cell Adhesion Molecules in Inflammatory Myopathies and Duchenne Dystrophy , 1994, Journal of neuropathology and experimental neurology.